Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Latixa“
Suchtreffer
Begriffe & Kennungen
Ranexa (previously Latixa) · 4.5 · Atorvastatin: Ranexa 1000 mg twice daily increased Cmax and AUC of atorvastatin 80 mg once daily by 1.4- and 1
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Atorvastatin: Ranexa 1000 mg twice daily increased Cmax and AUC of atorvastatin 80 mg once daily by 1.4- and 1
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Available data suggest that ranolazine is a mild inhibitor of CYP2D6. Ranexa 750 mg twice daily increased plas
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Available data suggest that ranolazine is a mild inhibitor of CYP2D6. Ranexa 750 mg twice daily increased plas
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP2D6 inhibitors: Ranolazine is partially metabolised by CYP2D6; therefore, inhibitors of this enzyme may inc
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP2D6 inhibitors: Ranolazine is partially metabolised by CYP2D6; therefore, inhibitors of this enzyme may inc
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP2D6 inhibitors: Ranolazine is partially metabolised by CYP2D6; therefore, inhibitors of this enzyme may inc
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 inducers: Rifampicin (600 mg once daily) decreases ranolazine steady-state concentrations by approximat
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 inducers: Rifampicin (600 mg once daily) decreases ranolazine steady-state concentrations by approximat
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 inducers: Rifampicin (600 mg once daily) decreases ranolazine steady-state concentrations by approximat
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 or P-gp inhibitors: Ranolazine is a substrate of cytochrome CYP3A4. Inhibitors of CYP3A4 increase plasm
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 or P-gp inhibitors: Ranolazine is a substrate of cytochrome CYP3A4. Inhibitors of CYP3A4 increase plasm
Eintrag öffnenRanexa (previously Latixa) · 4.5 · CYP3A4 or P-gp inhibitors: Ranolazine is a substrate of cytochrome CYP3A4. Inhibitors of CYP3A4 increase plasm
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Digoxin: An increase in plasma digoxin concentrations by an average of 1.5-fold has been reported when Ranexa
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Digoxin: An increase in plasma digoxin concentrations by an average of 1.5-fold has been reported when Ranexa
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Digoxin: An increase in plasma digoxin concentrations by an average of 1.5-fold has been reported when Ranexa
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Diltiazem (180 to 360 mg once daily), a moderately potent CYP3A4 inhibitor, causes dose-dependent increases in
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Diltiazem (180 to 360 mg once daily), a moderately potent CYP3A4 inhibitor, causes dose-dependent increases in
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Diltiazem (180 to 360 mg once daily), a moderately potent CYP3A4 inhibitor, causes dose-dependent increases in
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Dose adjustment of sensitive CYP3A4 substrates (e.g. simvastatin, lovastatin) and CYP3A4 substrates with a nar
Eintrag öffnen